Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Loans - Gross (2022 - 2023)

Silo Pharma's Loans - Gross history spans 2 years, with the latest figure at $69600.0 for Q4 2023.

  • For Q4 2023, Loans - Gross rose 5.44% year-over-year to $69600.0; the TTM value through Dec 2023 reached $69600.0, up 5.44%, while the annual FY2023 figure was $69600.0, 5.44% up from the prior year.
  • Loans - Gross for Q4 2023 was $69600.0 at Silo Pharma, up from $66010.0 in the prior quarter.
  • Across five years, Loans - Gross topped out at $69600.0 in Q4 2023 and bottomed at $66010.0 in Q4 2022.